912
Views
88
CrossRef citations to date
0
Altmetric
Research Article

Ocular HSV-1 Latency, Reactivation and Recurrent Disease

, , , , , , & show all
Pages 249-273 | Published online: 02 Jul 2009

REFERENCES

  • Abghari S Z, Stulting R, Petrash J. Detection of herpes simplex virus type 1 latency-associated transcripts in corneal cells of inbred mice by in situ hybridization. Cornea 1998; 11: 433–438
  • Ahmed M, Lock M, Miller C G, Fraser N W. Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo. J Virol 2002; 76: 717–729
  • Aloe L. Intraocular herpes simplex virus injection in neonatal rats induces sympathetic nerve cell destruction: effect of nerve growth factor. Int J Devl Neurosci 1987; 5: 357–366
  • Alwine J C, Steinhart L W, Hill W C. Transcription of herpes simplex type 1 DNA in nuclei isolated from infected HEp-2 and KB cells. Virology 1974; 60: 302–307
  • Amelio A L, Giordani V N, O'Neil J, Bloom C D. Deacetylation of the herpes simples virus type 1 latency-associated transcript (LAT) enhancer and a decrease in LAT abundance precede an increase in ICP0 transcriptional permissiveness at early times postexplant. J Virol 2006; 80: 2063–2068
  • Amelio A L, McAnany P K, Bloom D C. A chromatin insulator-like element in the herpes simplex virus type 1 latency-associated transcript region binds CCCTC-binding factor and displays enhancer-blocking and silencing activities. J Virol 2006; 80: 2358–2368
  • Ball M J, Matthews R, Steiner I, Hill J M, Wisner T W, Murdoch G H, Kohama S, Sexton G, Nagalla S. Latent HSV-1 virus in trigeminal ganglia: the optimal site for linking prevention of Alzheimer's disease to vaccination. Neurobiol Aging 2001; 22: 705–709
  • Banfield B W, Leduc Y, Esford L, Visalli R J, Brandt C R, Tufaro F. Evidence for an interaction of herpes simplex virus with chondroitin sulfate proteoglycans during infection. Virology 1995; 208: 531–539
  • Berman E J, Hill J M. Spontaneous ocular shedding of HSV-1 in latently infected rabbits. Invest Ophthalmol Vis Sci 1985; 26: 587–590
  • Beyer C F, Arens M Q, Hill J M, Rose B T, Hill G A, Lin DT C, C T. Penetrating keratoplasty in rabbits induces latent HSV-1 reactivation when corticosteroids are used. Curr Eye Res 1989; 8: 1323–1329
  • Beyer C F, Hill J, Reidy J, Beuerman R W. Corneal nerve disruption reactivates virus in rabbits latently infected with HSV-1. Invest Ophthalmol Vis Sci 1990; 31: 925–932
  • Beyer C F, Tepper D, Hill J. Cryogenic induced ocular HSV-1 reactivation is enhanced by an inhibitor of the lipoxygenase pathway. Curr Eye Res 1989; 8: 1287–1292
  • Bhattacharjee P S, Neumann D M, Stark D, Thompson H W, Hill J M. 2006. Apolipoprotein E modulates establishment of HSV-1 latency and survival in a mouse ocular model. Curr Eye Res 2006; 31: 703–708
  • Biondi M, Zannino L G. Psychological stress, neuroimmunomodulation, and susceptibility to infectious diseases in animals and man: a review. Psychother Psychosom 1997; 66: 3–26
  • Block T M, Deshmane S, Masonis J, Maggioncalda J, Valyi-Nagi T, Fraser N W, An H SV. LAT null mutant reactivates slowly from latent infection and makes small plaques on CV-1 monolayers. Virology 1993; 192: 618–630
  • Bloom D C. HSV-1 Latency and the Roles of the LATs, pp 325-342. Alpha Herpesviruses: Molecular and Cellular Biology, R. M. Sandri-Goldin. Caister Academic Press, NorflokUK 2006
  • Bloom D C, Devi-Rao G B, Hill J M, Stevens J G, Wagner E K. Molecular analysis of herpes simplex virus type 1 during epinephrine induced reactivation of latently infected rabbits. in vivo J Virol 1994; 68: 1283–1292
  • Bloom D C, Hill J M, Devi-Rao G, Wagner E K, Feldman L T, Stevens J G. A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J Virol 1996; 70: 2449–2459
  • Bloom D C, Stevens J G, Hill J M, Tran R K. Mutagenesis of a cAMP response element within the latency-associated transcript promoter of HSV-1 reduces adrenergic reactivation. Virology 1997; 236: 202–207
  • Bobrowski P J, Capiola R, Centifanto Y M. Latent herpes simplex virus reactivation in the guinea pig. An animal model for recurrent disease. Int J Dermatol 1991; 30: 29–35
  • Boutell C, Everett R D. The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with ubiquitinates p53. J Biol Chem 2003; 278: 36596–36602
  • Brandt C R. The role of viral and host genes in corneal infection with herpes simplex virus type 1. Exp Eye Res 2005; 80: 607–621
  • Bratcher D F, Harrison C J, Bourne N, Stanberry L R, Bernstein D I. Effect of indomethacin on ultraviolet radiation-induced recurrent herpes simplex virus disease in guinea-pigs. J Gen. Virol 1993; 74: 1951–1954
  • Burgos J S, Ramirez C, Sastre I, Bullido M J, Valdivieso F. Involvement of apolipoprotein E in the hematogenous route of herpes simplex virus type 1 to the central nervous system. J Virol 2002; 76: 12394–12398
  • Burgos J S, Ramirez C, Sastre I, Bullido M J, Valdivieso F. ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1. NeuroReport 2003; 14: 1825–1827
  • Burgos J S, Ramirez C, Sastre I, Valdivieso F. Effect of Apolipoprotein E on the Cerebral Load of Latent Herpes Simplex Virus Type 1 DNA. J Virol 2006; 80: 5383–5387
  • Bustos D E, Atherton S S. Detection of herpes simplex virus type 1 in human ciliary ganglia. Invest Ophthalmol Vis Sci 2002; 43: 2244–2249
  • Cai W, Astor T L, Liptak L M, Cho C, Coen D M, Schaffer P A. The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J Virol 1993; 67: 7501–7512
  • Carpenter D, Henderson G, Hsiang C, Osorio N, BenMohamed L, Jones C, Wechsler S L. Introducing point mutations into the ATGs of the putative open reading frames of the HSV-1 gene encoding the latency associated transcript (LAT) reduces its anti-apoptosis activity 1. Microb Pathog 2008; 44(2)98–102
  • Chen Q, Lin L, Smith S, Huang J, Berger S L, Zhou J. CTCF-dependent chromatin boundary element between the latency-associated transcript and ICP0 promoters in the herpes simplex virus type 1 genome. J Virol 2007; 81: 5192–5201
  • Chen S-H, Kramer M F, Schaffer P A, Coen D M. A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J Virol 1997; 71: 5878–5884
  • Clement C, Tiwari V, Scanlan P M, Valyi-Nagy T, Yue B Y, Shukla D. A novel role for phagocytosis-like uptake in herpes simplex virus entry. J Cell Biol 2006; 174: 1009–1021
  • Clements J B, Watson R J, Wilkie N M. Temporal regulation of herpes simplex virus type 1 transcription: Location of transcripts on the viral genome. Cell 1977; 12: 275–285
  • Coen D M, Richman D D. Antiviral Agents. Fields Virology, D. M. Knipe, P. M. Howley. Lippincott Williams & Wilkins, Philadelphia, PA 2007; vol. I: 448–486
  • Cohrs R J, Randall J, Smith J, Gilden D H, Dabrowski C, Van H, Keyl Der, Tal-Singer R. Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol 2000; 74: 11464–11471
  • Cook S D, Hill J M, Lynas C, Maitland N J. Latency-associated transcripts in corneas and ganglia of HSV-1 infected rabbits. Br J Ophthalmol 1991; 75: 644–648
  • Cook S D, Paveloff M J, Doucet J J, Cottingham A J, Sedarati F, Hill J M. Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants. Invest Ophthalmol Vis Sci 1991; 32: 1558–1561
  • Cosar C B, Sridhar M S, Cohen E J, Held E L, Alvim P T, Rapuano C J, Raber I M, Laibson P R. Indications for penetrating keratoplasty and associated procedures, 1996–2000. Cornea 2002; 21: 148–151
  • Costanzo F, Campadelli-Fiume G, Foa-Tomasi L, Cassai E. Evidence that herpes simplex virus DNA is transcribed by cellular RNA polymerase B. J Virol 1977; 21: 996–1001
  • Cunningham A L, Diefenbach R J, Miranda-Saksena M, Bosnjak L, Kim M, Jones C, Douglas M W. The cycle of human herpes simplex virus infection: virus transport and immune control. J Infect Dis 2006; 194(Suppl 1)S11–S18
  • Davison A J, Scott J E. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol 1986; 67: 1759–1816
  • Deshmane S L, Fraser N W. During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J Virol 1989; 63: 943–947
  • Devi-Rao G B, Bloom D C, Stevens J G, Wagner E K. Herpes simplex virus type 1 DNA replication and gene expression during explant induced reactivation of latently infected murine sensory ganglia. J Virol 1994; 68: 1271–1282
  • Divito S, Cherpes T L, Hendricks R L. A triple entente: virus, neurons, and CD8+ T cells maintain HSV-1 latency. Immunol Res 2006; 36: 119–126
  • Dixon R A, Schaffer P A. Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175. J Virol 1980; 36: 189–203
  • Dobson C B, Sales S D, Hoggard P, Wozniak M A, Crutcher K A. The receptor-binding region of human apolipoprotein E has direct anti-infective activity 1. J Infect Dis 2006; 193: 442–450
  • Drolet B S, Mott K R, Lippa A M, Wechsler S L, Perng G C, Glycoprotein C. of herpes simplex virus type 1 is required to cause keratitis at low infectious doses in intact rabbit corneas. Curr Eye Res 2004; 29: 181–189
  • Duman R S, Newton S S. Epigenetic marking and neuronal plasticity. Biol Psychiatry 2007; 62: 1–3
  • Efstathiou S, Minson A C, Field H J, Anderson J R, Wildy P. Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans. J Virol 1986; 57: 446–455
  • El Borai N, LeFevre C, Inoue M, Naumova E N, Sato K, Suzuki S, Tsuji K, Yamamura M. Presence of HSV-1 DNA in semen and menstrual blood. J Reprod Immunol 1998; 41: 137–147
  • Elgadi M M, Smiley J R. Picornavirus internal ribosome entry site elements target RNA cleavage events induced by the herpes simplex virus virion host shutoff protein. J Virol 1999; 73: 9222–9231
  • Epstein M A. Observations on the mode of release of herpes virus from infected HeLa cells. J Cell Biol 1962; 12: 589–597
  • Epstein S P, Nurozler M, Smetana C R, Asbell P A. Efficacy of polyclonal antibodies for treatment of ocular herpes simplex infection. Cornea 2001; 20: 495–500
  • Everett R D, Orr A, Elliott M. High level expression and purification of herpes simplex virus type 1 immediate early polypeptide Vmw110. Nucleic Acids Res 1991; 19: 6155–6161
  • Faber S W, Wilcox K W. Association of the herpes simplex virus regulatory protein ICP4 with specific nucleotide sequences in DNA. Nucleic Acids Res 1986; 14: 6067–6083
  • Farrell M J, Dobson A T, Feldman L T. Herpes simplex virus latency associated transcript is a stable intron. Proc Natl Acad Sci USA 1991; 88: 790–794
  • Fawl R L, Gesser R M, Valyi-Nagi T, Fraser N W. Reactivation of herpes simplex virus from latently infected mice after administration of cadmium is mouse-strain-dependent. J Gen Virol 1996; 77: 2781–2786
  • Fawl R L, Roizman B. Induction of reactivation of herpes simplex virus in murine sensory ganglia in vivo by cadmium. J Virol 1993; 67: 7025–7031
  • Feldman L T, Ellison A R, Voytek C C, Yang L, Krause P, Margolis T P. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci USA 2002; 99: 978–983
  • Fenwick M, Morse L S, Roizman B. Anatomy of herpes simplex virus DNA. XI. Apparent clustering of functions effecting rapid inhibition of host DNA and protein synthesis. J Virol 1979; 29: 825–827
  • Fine M, Cignetti F E. Penetrating keratoplasty in herpes simplex keratitis. Recurrence in grafts. Arch Ophthalmol 1977; 95: 613–616
  • Freeman M L, Sheridan B S, Bonneau R H, Hendricks R L. Psychological stress compromises CD8+ T cell control of latent herpes simplex virus type 1 infections. J Immunol 2007; 179: 322–328
  • Garber D A, Beverley S M, Coen D M. Demonstration of circularization of herpes simplex virus DNA following infection using pulsed field gel electrophoresis. Virology 1993; 197: 459–462
  • Garssen J, van der Molen R, de Klerk A, Norval M, van Loveren H. Effects of UV irradiation on skin and nonskin-associated herpes simplex virus infections in rats. Photochem Photobiol 2000; 72: 645–651
  • Gebhardt B M, Kaufman H E. Propranolol suppresses reactivation of herpesvirus. Antivir Res 1995; 27: 255–261
  • Gebhardt B M, Kaufman H E, Hill J M. Effect of acyclovir on thermal stress-induced herpesvirus reactivation. Curr Eye Res 2004; 29: 137–144
  • Gebhardt B M, Varnell E D, Hill J M, Kaufman H E. Animal models of ocular herpes simplex virus infection (rabbits, primates, mice). Handbook of Animal Models of Infection, O. Zak, M. Sande. Academic Press, London 1999; 919–926
  • Gebhardt B M, Varnell E D, Kaufman H E. Acetylsalicylic acid reduces viral shedding induced by thermal stress. Curr Eye Res 2004; 29: 119–126
  • Gebhardt B M, Varnell E D, Kaufman H E. Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation. J Ocul Pharmacol Ther 2005; 21: 114–120
  • Gelman I H, Silverstein S J. Herpes simplex virus immediate-early promoters are responsive to virus and cell trans-acting factors. J Virol 1987; 61: 2286–2296
  • Gerber S I, Belval B J, Herold B C. Differences in the role of glycoprotein C of HSV-1 and HSV- 2 in viral binding may contribute to serotype differences in cell tropism. Virology 1995; 214: 29–39
  • Gershon A A, Sherman D L, Zhu Z, Gabel C A, Ambron R T, Gershon M D. Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network. J Virol 1994; 68: 6372–6390
  • Goins W F, Sternberg L R, Croen K D, Krause P R, Hendricks R L, Fink D J, Straus S E, Levine M, Glorioso J C. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol 1994; 68: 2239–2252
  • Gordon Y J, Romanowski E, Araullo-Cruz T, McKnight J LC. HSV-1 corneal latency. Invest Ophthalmol Vis Sci 1991; 32: 663–665
  • Gordon Y J, Romanowski E, Harwick J, Berman J, Olsakovsky L, Araullo-Cruz T. The effect of alpha blockade on iontophoresis-induced ocular shedding of latent HSV-1 W in different host animals. Curr Eye Res 1990; 9: 1007–1014
  • Gordon Y J, Yates K A, Mah F S, Romanowski E G. The effects of Xalantan on the recovery of ocular herpes simplex virus type 1 (HSV-1) in the induced reactivation and spontaneous shedding rabbit models. J Ocular Pharmacol Therapeut 2003; 19: 233–245
  • Gordon Y, Romanowski E, Araullo-Cruz T. A fast, simple reactivation method for the study of HSV-1 latency in the rabbit ocular model. Invest Ophthalmol Vis Sci 1990; 31: 921–924
  • Granzow H, Klupp B G, Fuchs W, Veits J, Osterrieder N, Mettenleiter T C. Egress of alphaherpesviruses: comparative ultrastructural study. J Virol 2001; 75: 3675–3684
  • Green M, Rosborough J, Dunkel E. In vivo reactivation of herpes simplex virus in rabbit trigeminal ganglia: Electrode model. Infect Immun 1981; 34: 69–74
  • Guess S, Stone D U, Chodosh J. Evidence-based treatment of herpes simplex virus keratitis: a systematic review. Ocul Surf 2007; 5: 240–250
  • Hamza M A, Higgins D M, Feldman L T, Ruyechan W T. The latency-associated transcript of herpes simplex virus type 1 promotes survival and stimulates axonal regeneration in sympathetic and trigeminal neurons. J Neurovirol 2007; 13: 56–66
  • Harbour D A, Hill T J, Blyth W A. Recurrent herpes simplex in the mouse: inflammation in the skin and activation of virus in the ganglia following peripheral stimulation. J Gen Virol 1983; 64: 1491–1498
  • Harms J S, Ren X, Oliveira S C, Splitter G A. Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations. J Virol 2000; 74: 3301–3312
  • Haruta Y, Maguire L J, Rootman D S, Hill J M. Recurrent herpes simplex virus type 1 corneal epithelial lesions after radial keratotomy in the rabbit. Arch Ophthalmol 1987; 105: 692–694
  • Haruta Y, Rootman D S, Hill J M. Recurrent HSV-1 corneal epithelial lesions induced by Timolol iontophoresis in latently infected rabbits. Invest Ophthalmol Vis Sci 1988; 29: 387–392
  • Haruta Y, Rootman D S, Xie L, Kiritoshi A, Hill J M. Recurrent HSV-1 corneal lesions in rabbits induced by cyclophosphamide and dexamethasone. Invest Ophthalmol Vis Sci 1989; 30: 371–376
  • Heine J W, Honess R W, Cassai E, Roizman B. Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains. J Virol 1974; 14: 640–651
  • Herold B C, WuDunn D, Soltys N, Spear P G, Glycoprotein C. of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol 1991; 65: 1090–1098
  • Herpetic E ye, Disease Study Group. Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. Arch Ophthalmol 2000; 118: 1617–1624
  • Herpetic E ye, Disease Study Group. Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group. Cornea 2001; 20: 123–128
  • Higaki S, Gebhardt B, Lukiw W, Thompson H, Hill J. Gene expression profiling in the HSV-1 latently infected mouse trigeminal ganglia following hyperthermic stress. Curr Eye Res 2003; 26: 231–238
  • Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995; 375: 411–415
  • Hill J M, Bhattacharjee P S, Neumann D M, Apolipoprotein E. alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease. Exp Eye Res 2007; 85(5)801–811
  • Hill J M, Garza H H, Jr., Helmy M F, Cook S D, Osborne P A, Johnson E M, Jr., Thompson H W, Jr., Green L C, O'Callaghan R J, Gebhardt B M. Nerve growth factor antibody stimulates reactivation of ocular herpes simplex virus type 1 in latently infected rabbits. J Neurovirol 1997; 3: 206–211
  • Hill J M, Gebhardt B M, Wen R J, Bouterie A M, Thompson H W, O'Callaghan R J, Halford W P, Kaufman H E. Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency. J Virol 1996; 70: 3137–3141
  • Hill J M, Haruta Y, Rootman D S. Adrenergically induced recurrent HSV-1 corneal epithelial lesions. Curr Eye Res 1987; 6: 1065–1071
  • Hill J M, Kwon B S, Shimomura Y, Colborn G L, Yaghmai F, Gangarosa L P. Herpes simplex virus recovery in neural tissues after ocular HSV shedding induced by epinephrine iontophoresis to the rabbit cornea. Invest Ophthalmol Vis Sci 1983; 24: 243–247
  • Hill J M, Lukiw W J, Gebhardt B M, Higaki S, Loutsch J M, Myles M E, Thompson H W, Kwon B S, Bazan N G, Kaufman H E. Gene expression analyzed by microarrays in HSV-1 latent mouse trigeminal ganglion following heat stress. Virus Genes 2001; 23: 273–280
  • Hill J M, Rayfield M A, Haruta Y. Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits. Curr Eye Res 1987; 6: 91–97
  • Hill J M, Sedarati F, Javier R T, Wagner E K, Stevens J G. Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology 1990; 174: 117–125
  • Hill J M, Shimomura Y, Dudley J B, Berman E, Haruta Y, Kwon B S, Maguire L J. Timolol induces HSV-1 ocular shedding in the latently infected rabbit. Invest Ophthalmol Vis Sci 1987; 28: 585–590
  • Hill J M, Shimomura Y, Kwon B S, Gangarosa L P, Sr. Iontophoresis of epinephrine isomers to rabbit eyes induced HSV-1 ocular shedding. Invest Ophthalmol Vis Sci 1985; 26: 1299–1303
  • Hill J M, Wen R, Halford W P. Pathogenesis and molecular biology of ocular HSV in the rabbit. Herpes Simplex Virus Protocols, M. S. Brown, A. R. MacLean. Humana Press/Wiley, Totowa, NJ 1998; 291–315
  • Hill T J, Blyth W A, Harbour D A. Trauma to the skin causes recurrence of herpes simplex in the mouse. J Gen Virol 1978; 39: 21–28
  • Hodge W G, Margolis T P. Herpes simplex virus keratitis among patients who are positive or negative for human immunodeficiency virus. An epidemiologic study. Ophthalmology 1997; 104: 120–124
  • Hou Y C, Chen C C, Wang I J, Hu F R. Recurrent herpetic keratouveitis following YAG laser peripheral iridotomy. Cornea 2004; 23: 641–642
  • Huang S C, Wu W C, Tsai R J. Recurrent herpetic keratitis induced by laser iridectomy: case report. Changgeng Yi Xue Za Zhi 1999; 22: 515–519
  • Itzhaki R F, Lin W R, Shang D, Wilcock G K, Faragher B, Jamieson G A. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 1997; 349: 241–244
  • Izumi K M, McKelvey A M, Devi G B, B-Rao G, Wagner E K, Stevens J G. Molecular and biological characterization of a type 1 herpes simplex virus (HSV-1) specifically deleted for expression of the latency-associated transcript (LAT). Microb Pathog 1989; 7: 121–134
  • Jackson S A, DeLuca N A. Relationship of herpes simplex virus genome configuration to productive and persistent infections. Proc Natl Acad Sci USA 2003; 100: 7871–7876
  • Javier R T, Stevens J G, Dissette V B, Wagner E K. A herpes simplex virus transcript abundant in latently infected neurons is dispensable for establishment of the latent state. Virology 1988; 166: 254–257
  • Jenuwein T, Allis C D. Translating the histone code. Science 2001; 293: 1074–1080
  • Jerome K R, Fox R, Chen Z, Sarkar P, Corey L. Inhibition of apoptosis by primary isolates of herpes simplex virus. Arch Virol 2001; 146: 2219–2225
  • Ji Z S, Pitas R E, Mahley R W. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than E4. J Biol Chem 1998; 273: 13452–13460
  • Jin L, Perng G C, Carpenter D, Mott K R, Osorio N, Naito J, Brick D J, Jones C, Wechsler S L. Reactivation phenotype in rabbits of a herpes simplex virus type 1 mutant containing an unrelated antiapoptosis gene in place of latency-associated transcript. J Neurovirol 2007; 13: 78–84
  • Johnson E M, Manning P T, Wilcox C. The biology of nerve growth factor in vivo. Neurobiology of Amino Acids, Peptides, and Tropic Factors, J. A. Ferrendelli, R. C. Collins, E. M. Johnson. Kluwer Academic Publishers, London 1988; 101–114
  • Kaiserman I, Kaiserman N, Nakar S, Vinker S. Herpetic eye disease in diabetic patients. Ophthalmology 2005; 112: 2184–2188
  • Kaufman H E, Azcuy A M, Varnell E D, Sloop G D, Thompson H W, Hill J M. HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci 2005; 46: 241–247
  • Kaufman H E, Varnell E D, Gebhardt B M, Thompson H W, Hill J M. Propanolol suppression of ocular HSV-1 recurrence and associated corneal lesions following spontaneous reactivation in the rabbit. Curr Eye Res 1996; 15: 680–684
  • Kaufman H E, Varnell E D, Thompson H W. Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit. Am J Ophthalmol 1999; 127: 531–536
  • Kaye S, Choudhary A. Herpes simplex keratitis. Prog. Retin. Eye Res 2006; 25: 355–380
  • Kaye S B, Lynas C, Patterson A, Risk J M, McCarthy K, Hart C A. Evidence for herpes simplex viral latency in the human cornea. Br J Ophthalmol 1991; 75: 195–200
  • Keadle T L, Laycock K A, Miller J K, Hook K K, Fenoglio E D, Francotte M, Slaoui M, Stuart P M, Pepose J S. Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice. J Infect Dis 1997; 176: 331–338
  • Keadle T L, Laycock K A, Morris J L, Leib D A, Morrison L A, Pepose J S, Stuart P M. Therapeutic vaccination with vhs(-) herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice. J Gen Virol 2002; 83: 2361–2365
  • Kent J R, Zheng P-Y, Atanasiu D, Gardner J, Fraser N W, Berger S L. During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J Virol 2004; 78: 10178–10186
  • Khurana B, Kristie T M. A protein sequestering system reveals control of cellular programs by the transcriptional coactivator HCF-1. J Biol Chem 2004; 279: 33673–33683
  • Kibrick S, Takahashi G H, Leibowitz H M, Laibson P R. Local corticosteroid therapy and reactivation of herpetic keratitis. Arch Ophthalmol 1971; 86: 694–698
  • Kouzarides T. Chromatin modifications and their function. Cell 2007; 128: 693–705
  • Kriesel J D, Araneo B, Petajan J P, Spruance S L, Stromatt S. Herpes labialis associated with recombinant human ciliary neurotrophic factor. J Infect Dis 1994; 170: 1046
  • Kriesel J D, Gebhardt B M, Hill J M, Maulden S A, Hwang I P, Clinch T E, Cao X, Spruance S L, Araneo B A. Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation. J Infect Dis 1997; 175: 821–827
  • Kriesel J D, Pisani P L, McKeough M B. Correlation between detection of herpes simplex virus in oral secretions by PCR and susceptibility to experimental UV radiation-induced herpes labialis. J Infect Dis 1994; 170: 1046
  • Kriesel J D, Ricigliano J, Spruance S L, Garza H H, Jr., Hill J M. Neuronal reactivation of herpes simplex virus may involve interleukin-6. J Neurovirol 1997; 3: 441–448
  • Kristie T M, Roizman B. Separation of sequences defining basal expression from those conferring alpha gene recognition within the regulatory domains of herpes simplex virus 1 alpha genes. Proc Natl Acad Sci USA 1984; 81: 4065–4069
  • Kubat N J, Amelio A L, Giordani N V, Bloom D C. The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription. J Virol 2004; 78: 12518
  • Kubat N J, Tran R K, McAnany P, Bloom D C. Specific histone tail modification and not DNA methylation is a determinant of HSV-1 latent gene expression. J Virol 2004; 78: 1139–1149
  • Kwon B S, Gangarosa L P, Burch K D, deBack J, Hill J M. Induction of ocular herpes simplex virus shedding by iontophoresis of epinephrine into rabbit cornea. Invest Ophthalmol Vis Sci 1981; 21: 442–449
  • Kwon B S, Gangarosa L P, Green K, Hill J M. Kinetics of ocular herpes simplex virus shedding induced by epinephrine inotophoresis. Invest Ophthalmol Vis Sci 1982; 22: 818–821
  • Kwong A D, Frenkel N. Herpes simplex virus-infected cells contain a function(s) that destabilizes both host and viral mRNAs. Proc Natl Acad Sci USA 1987; 84: 1926–1930
  • Labetoulle M, Maillet S, Efstathiou S, Dezelee S, Frau E, Lafay F. HSV1 latency sites after inoculation in the lip: assessment of their localization and connection to the eye. Invest Ophthalmol Vis Sci 2003; 44: 217–225
  • Lafferty W E, Coombs R W, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987; 316: 1444–1449
  • Laibson P R, Kibrick S. Reactivation of herpetic keratitis by epinephrine in rabbits. Arch Ophthalmol 1966; 75: 254–260
  • Laibson P R, Kibrick S. Reactivation of herpetic keratitis in rabbits. II. Repeated reactivations in the same host. Arch Ophthalmol 1967; 77: 244–248
  • Lam Q, Smibert C A, Koop K E, Lavery C, Capone J P, Weinheimer S P, Smiley J R. Herpes simplex virus VP16 rescues viral mRNA from destruction by the virion host shutoff function. EMBO J 1996; 15: 2575–2581
  • LaVail J H, Tauscher A N, Hicks J W, Harrabi O, Melroe G T, Knipe D M. Genetic and molecular in vivo analysis of herpes simplex virus assembly in murine visual system neurons. J Virol 2005; 79: 11142–11150
  • Leah J D, Herdegen T, Bravo R. Selective expression of Jun proteins following axotomy and axonal transport block in peripheral nerves in the rat: evidence for a role in the regeneration process. Brain Res 1991; 566: 198–207
  • Leib D A, Bogard C L, Kosz-Vnenchak M, Hicks K A, Coen D M, Knipe D M, Schaffer P A. A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J Virol 1989; 63: 2893–2900
  • Leib D A, Nadeau K C, Rundle S A, Schaffer P A. The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: Role of the latency-associated transcripts and cAMP in reactivation of viral latency. Proc Natl Acad Sci USA 1991; 88: 48–52
  • Levy J, Lapid-Gortzak R, Klemperer I, Lifshitz T. Herpes simplex virus keratitis after laser in situ keratomileusis. J Refract Surg 2005; 21: 400–402
  • Li F Q, Sempowski G D, McKenna S E, Laskowitz D T, Colton C A, Vitek M P. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis. J Pharmacol Exp Ther 2006; 318: 956–965
  • Lieberman P M. Chromatin regulation of virus infection. Trends Microbiol 2006; 14: 132–140
  • Liedtke W, Opalka B, Zimmermann C W, Lignitz E. Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue. J Neurol Sci 1993; 116: 6–11
  • Liesegang T J. Herpes simplex virus epidemiology and ocular importance. Cornea 2001; 20: 1–13
  • Lin W R, Shang D, Wilcock G K, Itzhaki R F. Alzheimer's disease, herpes simplex virus type 1, cold sores and apolipoprotein E4. Biochem Soc Trans 1995; 23: 594S
  • Litt M D, Simpson M, Recillas-Targa F, Prioleau M-N, Felsenfeld G. Transitions in histone acetylation reveal boundaries of three separately regulated neighboring loci. EMBO J 2001; 20: 2224–2235
  • Lynas C, Cook S D, Laycock K A, Bradfield W JB, Maitland N J. Detection of latent virus mRNA in tissues using the polymerase chain reaction. J Pathol 1989; 157: 285–289
  • Lynch J R, Tang W, Wang H, Vitek M P, Bennett E R, Sullivan P M, Warner D S, Laskowitz D T. APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem 2003; 278: 48529–48533
  • Madan R P, Mesquita P M, Cheshenko N, Jing B, Shende V, Guzman E, Heald T, Keller M J, Regen S L, Shattock R J, Herold B C. Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections. J Virol 2007; 81: 7636–7646
  • Mahalingam R, Wellish M C, Dueland A N, Cohrs R J, Gilden D H. Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia. Ann Neurol 1992; 31: 444–448
  • Mahley R W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622–630
  • Mahley R W, Huang Y. Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology. Acta Neurologica Scandinavica 2006; 114: 8–14
  • Mahley R W, Rall S C. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1: 507–537
  • Manoj S, Jogger C R, Myscofski D, Yoon M, Spear P G. Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism. Proc Natl Acad Sci USA 2004; 101: 12414–12421
  • Margolis T P, Elfman F L, Leib D, Pakpour N, Apakupakul K, Imai Y, Voytek C. Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory Ganglia. J Virol 2007; 81: 11069–11074
  • Margolis T P, Imai Y, Yang L, Vallas V, Krause P R. Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts. J Virol 2007; 81: 1872–1878
  • Marquart M E, Zheng X, Tran R K, Thompson H W, Bloom D C, Hill J M. A cAMP response element within the latency-associated transcript promoter of HSV-1 facilitates induced ocular reactivation in a mouse hyperthermia model. Virology 2001; 284: 62–69
  • Martin R E, Henken D B, Hill J M. Altered expression and changing distribution of the nerve growth associated protein GAP-43 during ocular HSV-1 infection in the rabbit. J Neurovirol 1996; 2: 127–135
  • Martin R E, Loutsch J M, Garza H H, Jr., Boedeker D J, Hill J M. Iontophoresis of lysophosphatidic acid into rabbit cornea induces HSV-1 reactivation: evidence that neuronal signaling changes after infection. Mol Vis 1999; 5: 36
  • McAdoo J D, Warner D S, Goldberg R N, Vitek M P, Pearlstein R, Laskowitz D T. Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic-ischemic injury. Neurosci Lett 2005; 381: 305–308
  • Mehta A, Maggioncalda J, Bagasra O, Thikkavarapu S, Saikumari P, Valyi-Nagy T, Fraser N W, Block T M. In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice. Virology 1995; 206: 633–640
  • Mellerick D M, Fraser N W. Physical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal state. Virology 1987; 158: 265–275
  • Middleton G, Hamanoue M, Enokido Y, Wyatt S, Pennica D, Jaffray E, Hay R T, Davies A M. Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J Cell Biol 2000; 148: 325–332
  • Miller C S, Danaher R J. Asymptomatic shedding of herpes simplex virus (HSV) in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007, (in press)
  • Miller C S, Danaher R J, Jacob R J. Molecular aspects of herpes simplex virus 1 latency, reactivation and recurrence. Crit Rev Oral Biol Med 1998; 9: 541–562
  • Miller R M, Federoff H J. Isoform-specific effects of ApoE on HSV immediate early gene expression and establishment of latency. Neurobiol Aging. 2006, (in press)
  • Minson A C. Interactions of herpes simplex viruses with the host cell. Biochem Soc Trans 1994; 22: 298–301
  • Montgomery R I, Warner M S, Lum B J, Spear P G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 1996; 87: 427–36
  • Motani H, Sakurada K, Ikegaya H, Akutsu T, Hayakawa M, Sato Y, Yajima D, Sato K, Koayashi K, Iwase H. Detection of herpes simplex virus type 1 DNA in bilateral human trigeminal ganglia and optic nerves by polymerase chain reaction. J Med Virol 2006; 78: 1584–1587
  • Muller M T. Binding of the herpes simplex virus immediate-early gene product ICP4 to its own transcription start site. J Virol 1987; 61: 858–865
  • Myles M E, Alack C, Manino P M, Reish E R, Higaki S, Maruyama K, Mallakin A, Azcuy A, Barker S, Ragan F A, Thompson H W, Hill J M. Nicotine applied by transdermal patch induced HSV-1 reactivation and ocular shedding in latently infected rabbits. J Ocul Pharmacol Ther 2003; 19: 121–133
  • Myles M E, Azcuy A, Nguyen M, Reisch E R, Barker S, Thompson H W, Hill J M. Bupropion (Zyban, Wellbutrin) inhibits nicotine-induced viral reactivation in herpes simplex virus type 1 latent rabbits. J Pharmacol Exp Ther 2004; 311: 640–644
  • Nahmias A J, Lee F K, Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 1990; 69: 19–36
  • Naito J, Mukerjee R, Mott K R, Kang W, Osorio N, Fraser N W, Perng G C. Identification of a protein encoded in the herpes simplex virus type 1 latency associated transcript promoter region. Virus Res 2005; 108: 101–110
  • Nakayama J, Rice J C, Strahl B D, Allis C D, Grewal S I. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 2001; 292: 110–113
  • Nesburn A B, Burke R L, Ghiasi H, Slanina S M, Wechsler S L. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits. Virology 1998; 252: 200–209
  • Nesburn A B, Burke R L, Ghiasi H, Slanina S M, Wechsler S L. Therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal disease. Invest Ophthalmol Vis Sci 1998; 39: 1163–1170
  • Nesburn A B, Dickinson R, Radnoti M. The effect of trigeminal nerve and ganglion manipulation on recurrence of ocular herpes simplex in rabbits. Invest Ophthalmol 1976; 15: 726–731
  • Nesburn A B, Green M T, Radnoti M, Walker B. Reliable in vivo model for latent herpes simplex virus reactivation with peripheral virus shedding. Infect Immun 1977; 15: 772–775
  • Neumann D M, Bhattacharjee P S, Giordani N V, Bloom D C, Hill J M. In vivo changes in the patterns of chromatin structure associated with the latent HSV-1 genome in the mouse trigeminal ganglia can be detected at early times after butyrate treatment. J Virol. 2007, (in press)
  • Neumann D M, Bhattacharjee P S, Hill J M. Sodium butyrate: a chemical inducer of in vivo reactivation of herpes simplex virus type 1 in the ocular mouse model. J Virol 2007; 81: 6106–6110
  • Nicola A V, Hou J, Major E O, Straus S E. Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway. J Virol 2005; 79: 7609–7616
  • Norn M S. Dendritic (herpetic) keratitis. I. Incidence—seasonal variations—recurrence rate—visual impairment—therapy. Acta Ophthalmol (Copenh) 1970; 48: 91–107
  • O'Brien W J, Taylor J L. The isolation of herpes simplex virus from rabbit corneas during latency. Invest Ophthalmol Vis Sci 1989; 30: 357–364
  • O'Brien W J, Tsao L-S, Taylor J L. Tissue-specific accumulation of latency-associated transcripts in herpes virus-infected rabbits. Invest Ophthalmol Vis Sci 1998; 39: 1847–1853
  • O'Neil J E, Loutsch J M, Aguilar J S, Hill J M, Wagner E K, Bloom D C. Wide variations in HSV-1 inoculum dose and LAT expression phenotype do not alter the establishment of latency in the rabbit eye model. J Virol 2004; 78: 5038–5044
  • Ohara P T, Chin M S, LaVail J H. The spread of herpes simplex virus type 1 from trigeminal neurons to the murine cornea: an immunoelectron microscopy study. J Virol 2000; 74: 4776–4786
  • Ohlsson R, Renkawitz R, Lobanenkov V. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet 2001; 17: 520–527
  • Openshaw H. Latency of herpes simplex virus in ocular tissue of mice. Infect Immun. 1983; 39: 960–962
  • Peles E, Rosen H, Darai G, Rösen-Wolff A, Becker Y. Importance of the HpaI-P sequence for herpes simplex virus-1 replication in the adrenal glands. Arch Virol 1990; 113: 151–163
  • Penfold M ET, Armati P, Cunningham A L. Axonal transport of herpes simplex virions to epidermal cells: Evidence for a specialized mode of virus transport and assembly. Proc Natl Acad Sci USA 1994; 91: 6529–6533
  • Peng W, Henderson G, Perng G C, Nesburn A B, Wechsler S L, Jones C. The gene that encodes the herpes simplex virus type 1 latency-associated transcript influences the accumulation of transcripts (Bcl-x(L) and Bcl-x(S)) that encode apoptotic regulatory proteins. J Virol 2003; 77: 10714–10718
  • Pepose J S, Keadle T L, Morrison L A. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am J Ophthalmol 2006; 141: 547
  • Perng G C, Ghiasi H, Slanina S M, Nesburn A B, Wechsler S L. The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript. J Virol 1996; 70: 976–984
  • Perng G C, Slanina S M, Yukht A, Ghiasi H, Nesburn A B, Wechsler S L. The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits. J Virol 2000; 74: 1885–1891
  • Perng G-C, Esmaili D, Slanina S M, Yukht A, Ghiasi H, Osorio N, Mott K R, Maguen B, Jin L, Nesburn A B, Wechsler S L. Three herpes simplex virus type 1 latency-associated transcript mutants with distinct and asymmetric effects on virulence in mice compared with rabbits. J Virol 2001; 75: 9018–9028
  • Perng G-C, Jones C, Ciacci-Zanella J, Stone M, Henderson G, Yukht A, Slanina S M, Hofman F M, Ghiasi H, Nesburn A B, Wechsler S L. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 2000; 287: 1500–1503
  • Perng G-C, Maguen B, Jin L, Mott K R, Kurylo J, BenMohamed L, Yukht A, Osorio N, Nesburn A B, Henderson G, Inman M, Jones C, Wechsler S L. A novel herpes simplex virus type 1 transcript (AL-RNA) antisense to the 5′ end of the latency-associated transcript produces a protein in infected rabbits. J Virol 2002; 76: 8003–8010
  • Perng G-C, Maguen B, Jin L, Mott K R, Osorio N, Slanina S M, Yukht A, Ghiasi H, Nesburn A B, Inman M, Henderson G, Jones C, Wechsler S L. A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels. J Virol 2002; 76: 1224–1235
  • Peters A H, Mermoud'Carroll J E, Pagani M, Schweizer D, Brockdorff N, Jenuwein T. Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin. Nat Genet 2002; 30: 77–80
  • Pevenstein S R, Williams R K, McChesney D, Mont E K, Smialek J E, Straus S E. Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J Virol 1999; 73: 10514–10518
  • Pivetti-Pezzi P, Accorinti M, Colabelli R A, A-Gisoldi R, Pirraglia M P, Sirianni M C. Herpes simplex virus vaccine in recurrent herpetic ocular infection. Cornea 1999; 18: 47–51
  • Posavad C M, Koelle D M, Corey L. Tipping the scales of herpes simplex virus reactivation: The important responses are local. Nature Med 1998; 4: 381–382
  • Remeijer L, Doornenbal P, Geerards A JM, Rijneveld W A, Beekhuis W H. Newly acquired herpes simplex virus keratitis after penetrating keratoplasty. Ophthalmology 1997; 104: 648–652
  • Remeijer L, Maertzdorf J, Buitenwerf J, Osterhaus A D, Verjans G M. Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis. Invest Ophthalmol Vis Sci 2002; 43: 358–363
  • Rezende R A, Bisol T, Hammersmith K, Hofling A L, L-Lima A, Webster G F, Freitas J F, Rapuano C J, Laibson P R, Cohen E J. Epithelial herpetic simplex keratitis recurrence and graft survival after corneal transplantation in patients with and without atopy. Am J Ophthalmol 2007; 143: 623–628
  • Robertson L M, MacLean A R, Brown S M. Peripheral replication and latency reactivation kinetics of the non-neurovirulent herpes simplex virus type 1 variant 1716. J Gen Virol 1992; 73: 967–970
  • Rock D L, Nesburn A B, Ghiasi H, Ong J, Lewis T L, Lokensgard J R, Wechsler S L. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J Virol 1987; 61: 3820–3826
  • Roizman B, Knipe D M, Whitley R J. Herpes simplex viruses. Fields Virology, D. M. Knipe, P. M. Howley. Lippincott Williams & Wilkins. 2007; 2503–2602
  • Rootman D S, Haruta Y, Hill J M. Reactivation of HSV-1 in primates by transcorneal iontophoresis of adrenergic agents. Invest. Ophthalmol. Vis. Sci. 1990; 31: 597–600
  • Rootman D S, Haruta Y, Hill J M, Kaufman H E. Corneal nerves are necessary for adrenergic reactivation of ocular herpes. Invest Ophthalmol Vis Sci 1988; 29: 351–356
  • Sacks S L, Griffiths P D, Corey L, Cohen C, Cunningham A, Dusheiko G M, Self S, Spruance S, Stanberry L R, Wald A, Whitley R J. HSV shedding. Antiviral Res 2004; 6(3 Suppl 1)S19–S26
  • Sainz B, Jr., Loutsch J M, Marquart M E, Hill J M. Stress-associated immunomodulation and herpes simplex virus infection. Med Hypotheses 2001; 56: 348–356
  • Sandri-Goldin R M. Replication of the herpes simplex virus genome: does it really go around in circles?. Proc Natl Acad Sci USA 2003; 100: 7428–7429
  • Sawtell N M. Comprehensive quantification of herpes simplex virus latency at the single-cell level. J Virol 1997; 71: 5423–5431
  • Sawtell N M. The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J Virol 1998; 72: 6888–6892
  • Sawtell N M, Poon D K, Tansky C S, Thompson R L. The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J Virol 1998; 72: 5343–5350
  • Sawtell N M, Thompson R L. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J Virol 1992; 66: 2150–2156
  • Schmidt D D, Schmidt P M, Crabtree B F, Hyun J, Anderson P, Smith C. The temporal relationship of psychosocial stress to cellular immunity and herpes labialis recurrences. Fam. Med 1991; 23: 594–599
  • Sears A E, Roizman B. Amplification by host cell factors of a sequence contained within the herpes simplex virus 1 genome. Proc Natl Acad Sci USA 1990; 87: 9441–9444
  • Sedarati F, Izumi K M, Wagner E K, Stevens J G. Herpes simplex virus type 1 latency-associated transcription plays no role in establishment or maintenance of a latent infection in murine sensory neurons. J Virol 1989; 63: 4455–4458
  • Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem 2006; 75: 243–269
  • Shimeld C, Hill T J, Blyth W A, Easty D L. Reactivation of latent infection and induction of recurrent herpetic eye disease in mice. J Gen Virol 1990; 71: 397–404
  • Shimomura Y, Dudley J B, Gangarosa L P, Hill J M. HSV-1 quantitation from rabbit neural tissues after epinephrine-induced reactivation. Invest Ophthalmol Vis Sci 1985; 26: 121–125
  • Shimomura Y, Gangarosa L P, Sr., Kataoka M, Hill J M. HSV-1 shedding by iontophoresis of 6-hydroxydopamine followed by topical epinephrine. Invest Ophthalmol Vis Sci 1983; 24: 1588–1594
  • Shtein R M, Stahl R M, Saxe S J, Mian S I. Herpes simplex keratitis after intravitreal triamcinolone acetonide. Cornea 2007; 26: 641–642
  • Shukla D, Liu J, Blaiklock P, Shworak N W, Bai X, Esko J D, Cohen G H, Eisenberg R J, Rosenberg R D, Spear P G. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 1999; 99: 13–22
  • Sims R J, III, Nishioka K, Reinberg D. Histone lysine methylation: a signature for chromatin function. Trends Genet 2003; 19: 629–639
  • Smith J S, Robinson N J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002; 186: S3–S28
  • Smith T J, Ackland C E, E-Berglund C, Leib D A. Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice. J Virol 2000; 74: 3598–3604
  • Spear P G. Membrane fusion induced by herpes simplex virus. In Viral Fusion Mechanisms, J. Bentz. CRC Press, Inc., Boca Raton, FL 1993; 201–232
  • Spear P G, Longnecker R. Herpes virus entry: an update. J Virol 2003; 77: 10179–10185
  • Stanberry L R, Kern E R, Richards J T, Abbott T M, Overall J CJ. Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. J Infect Dis 1982; 146: 397–404
  • Stanberry L R, Spruance S L, Cunningham A L, Bernstein D I, Mindel A, Sacks S, Tyring S, Aoki F Y, Slaoui M, Denis M, Vandepapeliere P, Dubin G. Glycprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347: 1652–1661
  • Steiner I, Spivack J G, Lirette R P, Brown S M, MacLean A R, Subak J H, H-Sharpe J, Fraser N W. Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J 1989; 8: 505–511
  • Sterk C C, Jager M J, Swart M., Berg V D. Recurrent herpetic keratitis in penetrating keratoplasty. Doc Ophthalmol 1995; 90: 29–33
  • Stevens J G, Wagner E K, Devi G B, B-Rao G, Cook M L, Feldman L T. RNA complementary to a herpesvirus a gene mRNA is prominent in latently infected neurons. Science 1987; 235: 1056–1059
  • Strahl B D, Allis C D. The language of covalent histone modifications. Nature 2000; 403: 41–45
  • Strelow L I, Leib D A. Analysis of conserved domains of UL41 of herpes simplex virus type 1 in virion host shutoff and pathogenesis. J Virol 1996; 70: 5665–5667
  • Subramanian R P, Geraghty R J. Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B. Proc Natl Acad Sci USA 2007; 104: 2903–2908
  • Takasu T, Furuta Y, Sato K C, Fukuda S, Inuyama Y, Nagashima K. Detection of latent herpes simplex virus DNA and RNA in human geniculate ganglia by the polymerase chain reaction. Acta Otolaryngol (Stockh.) 1992; 112: 1004–1011
  • Tal-Singer R, Lasner T M, Podrzucki W, Skokotas A, Leary J J, Berger S L, Fraser N W. Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J Virol 1997; 71: 5268–5276
  • Tal-Singer R, Podrzucki W, Lasner T M, Skokotas A, Leary J J, Fraser N W, Berger S L. Use of differential display reverse transcription-PCR to reveal cellular changes during stimuli that result in herpes simplex virus type 1 reactivation from latency: Upregulation of immediate- early cellular response genes TIS7, interferon, and interferon regulatory factor-1. J Virol 1998; 72: 1252–1261
  • Thomas J, Rouse B T. Immunopathogenesis of herpetic ocular disease. Immunol Res 1997; 16: 375–386
  • Thomas S K, Gough G, Latchman D R, Coffin R S. Herpes simplex virus latency-associated transcript encodes a protein which greatly enhances virus growth, can compensate for deficiencies in immediate-early gene expression, and is likely to function during reactivation from virus latency. J Virol 1999; 73: 6618–6625
  • Thomas S K, Lilley C E, Latchman D S, Coffin R S. A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome. J Virol 2002; 76: 4056–4067
  • Thompson R L, Sawtell N M. The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J Virol 1997; 71: 5432–5440
  • Thompson R L, Sawtell N M. HSV latency-associated transcript and neuronal apoptosis. Science 2000; 289: 1651–165
  • Thompson R L, Sawtell N M. Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J Virol 2001; 75: 6660–6675
  • Tomishima M J, Smith G A, Enquist L W. Sorting and transport of alpha herpesviruses in axons. Traffic 2001; 2: 429–436
  • Trousdale M D, Steiner I, Spivack J G, Deshmane S L, Brown S M, MacLean A R, Subak J H, H-Sharpe J, Fraser N W. In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model. J Virol 1991; 65: 6989–6993
  • Uchio E, Hatano H, Ohno S. Altering clinical features of recurrent herpes simplex virus-induced keratitis. Ann Ophthalmol 1993; 25: 271–276
  • Van R J, Rijneveld W J, Remeijer L J, Beekhuis W H. A retrospective study on the effectiveness of oral acyclovir to prevent herpes simplex recurrence in corneal grafts. Eur J Ophthalmol 1995; 5: 214–218
  • van Lint A L, Torres-Lopez E, Knipe D M. Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease. Virology 2007; 368: 227–231
  • Varnell E D, Kaufman H E, Hill J M, Thompson H W. Cold stress-induced recurrence of herpetic keratitis in the squirrel monkey. Invest Ophthalmol Vis Sci 1995; 36: 1181–1183
  • Verjans G M, Hintzen R Q, van Dun J M, Poot A, Milikan J C, Laman J D, Langerak A W, Kinchington P R, Osterhaus A D. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc Natl Acad Sci USA 2007; 104: 3496–3501
  • Vlazny D A, Kwong A, Frenkel N. Site-specific cleavage/packaging of herpes simplex virus DNA and the selective maturation of nucleocapsids containing full-length viral DNA. Proc Natl Acad Sci USA 1982; 79: 1423–1427
  • Walker J, Laycock K A, Pepose J S, Leib D A. Postexposure vaccination with a virion host shutoff defective mutant reduces UV-B radiation-induced ocular herpes simplex virus shedding in mice. Vaccine 1998; 16: 6–8
  • Wand M, Gilbert C M, Liesegang T J. Latanoprost and herpes simplex keratitis. Am J Ophthalmol 1999; 127: 602–604
  • Wander A H, Bubel H C, McDowell S G. The pathogenesis of herpetic ocular disease in the guinea pig. Arch Virol 1987; 95: 197–209
  • Wander A H, Centifanto Y M, Kaufman H E. Strain specificity of clinical isolates of herpes simplex virus. Arch Ophthalmol 1980; 98: 1458–1461
  • Wang H, Durham L, Dawson H, Song P, Warner D S, Sullivan P M, Vitek M P, Laskowitz D T. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction. Neuroscience 2007; 144: 1324–1333
  • Wang Q Y, Zhou C, Johnson K E, Colgrove R C, Coen D M, Knipe D M. Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection. Proc Natl Acad Sci USA 2005; 102: 16055–16059
  • West A G, Gaszner M, Felsenfeld G. Insulators: many functions, many mechanisms. Genes Dev 2002; 16: 271–288
  • Wilcox C L, Johnson E M, Jr. Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro. J Virol 1988; 62: 393–399
  • Willey D E, Trousdale M D, Nesburn A B. Reactivation of murine latent HSV infection by epinephrine iontophoresis. Invest Ophthalmol Vis Sci 1984; 25: 945–950
  • Wishart M S, Darougar S, Viswalingam N D. Recurrent herpes simplex virus ocular infection: epidemiological and clinical features. Br J Ophthalmol 1987; 71: 669–672
  • Wu T T, Su Y H, Block T M, Taylor J M. Evidence that two latency-associated transcripts of herpes simplex virus type 1 are nonlinear. J Virol 1996; 70: 5962–5967
  • Wu Dunn D, Spear P G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol 1989; 63: 52–58
  • Yamamoto Y, Hill J M. HSV-1 recovery from ocular tissues after viral inoculation into the superior cervical ganglion. Invest Ophthalmol Vis Sci 1986; 27: 1447–1452
  • Yang L, Voytek C C, Margolis T P. Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1. J Virol 2000; 74: 209–217
  • York I A, Roop C, Andrews D W, Riddell S R, Graham F L, Johnson D C. A cytosolic herpes simplex virus protein inhibits antigen presentation to CH8+ T lymphocytes. Cell 1994; 77: 525–535
  • Yoshikawa T, Hill J M, Stanberry L R, Bourne N, Kurawadwala J F, Krause P R. The characteristic site-specific reactivation phenotypes of HSV- 1 and HSV-2 depend upon the latency-associated transcript region. J Exp Med 1996; 184: 659–664
  • Yu W, Ginjala V, Pant V, Chernukhin I, Whitehead J, Docquier F, Farrar D, Tavoosidana G, Mukhopadhyay R, Kanduri C, Oshimura M, Feinberg A P, Lobanenkov V, Klenova E, Ohlsson R. Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation. Nat Genet 2004; 36: 1105–1110
  • Zheng X, Marquart M E, Loutsch J M, Shah P, Sainz B, Ray A, O'Callaghan R J, Kaufman H E, Hill J M. HSV-1 migration in latently and naive rabbits after penetrating keratoplasty. Invest Ophthalmol Vis Sci 1999; 40: 2490–2497
  • Zhu J, Kang W, Marquart M E, Hill J M, Zheng X, Block T M, Fraser N W. Identification of a novel 0.7 kb polyadenylated transcript in the LAT promoter region of HSV-1 that is strain specific and may contribute to virulence. Virology 1999; 265: 296–307

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.